Abstract: In the realm of education, the timely identification of potential challenges, such as learning difficulties leading to dropout risks, and the facilitation of personalized learning, ...
Sagimet Biosciences has entered into a global, exclusive license agreement with TAPI covering resmetirom API intellectual property. The agreement supports technical evaluation, manufacturing, and ...
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback